Ulinastatin (Jiangsu Aidea Pharmaceutical)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameUlinastatin (Jiangsu Aidea Pharmaceutical)
Drug Alias NameAD-105
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTrypsin inhibitors
TargetsTrypsin
Therapy Area/IndicationsSystemic Inflammatory Response SyndromeHepatic Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Aidea Pharmaceutical Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Aidea Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsSystemic Inflammatory Response SyndromeHepatic Insufficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A